Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

November 24, 2020

GSK begins patient dosing in phase 3 trial of RSV maternal candidate vaccine

British drugmaker GlaxoSmithKline (GSK) has started patient dosing in a phase 3 clinical trial to assess the safety and efficacy of the respiratory syncytial viirus (RSV) vaccine candidate for maternal immunisation.

GSK begins patient dosing in phase 3 trial of RSV maternal candidate vaccine